Cholesterol and
Metabolic care

$199/month

Board-certified in clinical lipidology and obesity medicine. 25+ years experience, thousands of patients successfully treated. Telemedicine available nationally.

Start care How it works
  • Licensed in all 50 states & DC
  • Board-certified lipidologist
  • FNLA
  • 25+ years
  • Thousands of patients

Dr. Steven Winiarski

Dr. Steven Winiarski is triple board-certified — in Family Medicine, Clinical Lipidology, and Obesity Medicine — and was named a Fellow of the National Lipid Association in 2025. He completed his undergraduate studies at Emory University, earned his medical degree from the Chicago College of Osteopathic Medicine, and has spent more than twenty-five years managing complex lipid and metabolic disease.

Clinically, his focus is the full range of lipid disorders: mixed dyslipidemia, hypertriglyceridemia, resistant hypercholesterolemia, elevated lipoprotein(a), familial hypercholesterolemia, and statin intolerance. That work depends on advanced cardiovascular risk assessment — ApoB, Lp(a), advanced lipid testing, and vascular imaging — because the goal is to know what a given patient's arteries are actually doing rather than to estimate it from a standard panel.

He treats metabolic health as inseparable from lipid health, since insulin resistance drives the inflammation, the triglyceride burden, and the visceral adiposity that make dyslipidemia harder to control and atherosclerosis more aggressive. A competitive triathlete with a long-standing interest in exercise physiology, strength training, and nutrition, he considers diet and exercise the first line of treatment in every case, and reaches for pharmacology when the physiology does not respond to lifestyle alone.

Atherosclerosis sits where three systems overlap.

Atherosclerosis at the intersection of lipid metabolism, glucose metabolism, and inflammation Three overlapping translucent spheres arranged in a triangle — lipid metabolism, glucose metabolism, and inflammation. Atherosclerosis sits in the dense core where all three overlap. LIPID METABOLISM GLUCOSE METABOLISM INFLAMMATION ATHEROSCLEROSIS

Hover or tap each system

Treat all three and you are treating what drives heart disease, stroke, type 2 diabetes, kidney disease, dementia, and the cancers linked to insulin resistance.

Five steps. No waiting room.

  1. 1 Today

    Sign up

    Create your chart on SigmaMD and pick your appointment time.

  2. 2 Week 1

    First appointment

    Full lipid and metabolic history by video. You leave with a plan.

  3. 3 Day 30–45

    Labs & imaging

    Ordered if needed. Billed to your insurance, not your membership.

  4. 4 Follow-up

    Review & adjust

    We go through your results together and tune the plan.

  5. 5 Ongoing

    Year-round management

    Medications managed all year. Labs every 8–12 weeks as needed.

What We Treat

Prescribed when needed: statins · ezetimibe · bempedoic acid · Repatha · Leqvio · Lipfendra (oral PCSK9) · Ozempic · ZepboundFDA-approved only. Never compounded. Medication cost not included.

A zero calcium score is not a clean bill of health.

Calcium scans miss soft plaque, and the coronaries are one of six beds where plaque does damage. Labs tell you your risk. Imaging tells you what you already have.

Six vascular beds

Coronary, carotid, aortic, iliofemoral, peripheral, cerebral.

Imaging, not guesswork

CAC, carotid ultrasound, and CTA ordered and read with you.

ApoB over LDL-C

Particle burden is what damages the artery. We treat to it.

Intensity matched to you

Some need one modest dose. Some need aggressive combination therapy.

What Patients Say

7 reviews · 5.0 average

★★★★★

"Very impressed. I've never had a doctor visit where I've been asked so many questions and was able to truly explain my medical history and my health goals. It was honestly refreshing."

JW

John W.

Santa Barbara, CA
★★★★★

"Dr. Winiarski is the best doctor! He is VERY in-tune to how the entire body works and what the latest science is for treatments. I have been going to him for years and can honestly say no doctor has his level of attention to detail and insight into treatment options."

EO

Eugene O.

Atlanta, GA
★★★★★

"I would ONLY recommend this doctor for people looking for a nice, friendly, intelligent and caring doctor."

BB

Becca B.

Brooklyn, NY
★★★★★

"Dr. Winiarski was thoughtful, knowledgeable and deliberate in his delivery of information. I came to him after a cardiologist told me that I would have a heart attack in 10 years — 95%. Steven helped me understand its true meaning based on all factors."

TM

Thomas M.

San Diego, CA
★★★★★

"Awesome doctor. He is quite possibly the best doctor I have seen. He actually listens to you and tries to help. Wonderful bedside manner as well as personality."

JE

Jonathan E.

San Francisco, CA
★★★★★

"I haven't had a doctor listen to me that well in a long time (or really ever). That really stood out to me along with his breadth of knowledge with my issues and his desire to help with nutritional guidance as well."

MR

Meg R.

Atlanta, GA
★★★★★

"Dr. Winiarski took the time to listen to me and provided me with information and goals that complimented and added to the plan I had been prescribed by my endocrinologist. I feel that I am in good hands."

WK

Walter K.

Atlanta, GA

Membership

Every tier is built on the same foundation of ApoB-guided lipid care, metabolic assessment, and imaging when it is warranted. The tiers differ in visit frequency, scope, and access rather than in quality of thinking.

Billed annually — two months free on $199 plans

Lipid Care

$199/mo $1,999/yr
ApoB-guided cholesterol management.
  • Video visit every 12 weeks
  • ApoB & Lp(a) testing
  • Statins, ezetimibe, PCSK9 inhibitors
  • Statin intolerance & FH
  • Imaging ordered & interpreted

GLP-1 Care

$199/mo $1,999/yr
GLP-1 therapy, insulin resistance, weight.
  • Video visit every 8 weeks
  • Ozempic / Wegovy / Zepbound
  • Insulin resistance & prediabetes
  • Type 2 diabetes management
  • FDA-approved only, never compounded
Best Value

Lipid + GLP-1

$299/mo $2,999/yr
Both programs. Save $99/mo.
  • Everything in both plans
  • Video visit every 8 weeks
  • Full lipid + metabolic workup
  • All medications above

Concierge

$999/mo $10,999/yr
Direct line, mobile phlebotomy, bespoke care.
  • Everything in Lipid + GLP-1
  • Mobile phlebotomy every 12 weeks*
  • Unlimited messaging to private phone
  • Specialist referral & imaging coordination
  • *Where available
Book a call

Cancel anytime. Licensed in all 50 states and DC. Labs and imaging are billed to your insurance, not your membership; medication cost is not included. HSA/FSA receipts provided.

From the Blog

Evidence-based writing on lipidology, longevity, and metabolic health.

Longevity · Prevention

The Roadmap to Our Demise — And How to Navigate Around It

Extending lifespan isn't the same as extending healthspan. Why the highest-return longevity strategies are exercise, diet, and knowing your own physiology — not the next trending supplement.

April 15, 2026 Read more →
Testosterone · Metabolic Health

Testosterone Is a Metabolic Marker — The Symptom We're Treating as the Disease

In most men with low testosterone, the hormone is a readout of underlying metabolic dysfunction — not an independent disease. What the data show, and how to work it up properly.

May 14, 2026 Read more →
Atherosclerosis · Screening

Asymptomatic Isn't Absent — What the PESA Study Says About the Disease You Already Have

By the time chronic disease produces symptoms, it has been present for years. What the PESA study reveals about the disease most "low-risk" middle-aged adults already have.

May 18, 2026 Read more →
Atherosclerosis · Metabolic Health

Drivers Beneath the Numbers — What's Actually Causing Subclinical Atherosclerosis

The drivers of atherosclerosis are earlier and more diffuse than the standard panel suggests: visceral fat (not BMI), oxidized LDL, diet pattern, and sleep.

May 20, 2026 Read more →
Brain Health · Prevention

Your Brain Is a Vascular Organ — PESA, Dementia, and the APOE4 Question

The same disease that damages the carotid artery damages the cortex. What the PESA brain data and the APOE4 evidence mean for dementia prevention.

May 20, 2026 Read more →
Exercise · Longevity

Train the Variable, Not the Marker — VO2max, Mitochondria, and Where to Spend Your Hours

VO2max captures the macro level of your physiology, but the micro level lives in your mitochondria. How to train both halves — and where to spend limited exercise time.

May 20, 2026 Read more →
Diet · Cholesterol

Dietary Saturated Fat and Cholesterol

There is ongoing debate about whether dietary saturated fat increases cholesterol levels. In reality, both sides of the argument contain some truth: some individuals can increase saturated fat intake without significant changes in cholesterol levels, while others experience substantial increases.

January 21, 2024 Read more →
Omega-3 · Heart Disease

Can Fish Oil Actually Worsen Heart Health?

Researchers have been evaluating earlier studies suggesting that omega-3 fatty acids (EPA and DHA) improve cardiovascular health. Some recent findings, however, have raised questions about whether certain fish oil formulations may worsen certain outcomes.

February 12, 2024 Read more →
Cholesterol · Heart Disease

The Puzzle of Cardiovascular Disease

Cardiovascular disease kills more than 800,000 people in the United States each year, many of whom could be saved through early treatment. Understanding how cholesterol fits into a much larger risk picture is essential to effective prevention.

March 10, 2024 Read more →
Statins · Heart Disease

A Simple Framework I Use With Patients When Thinking About Long-Term Medications

In clinical practice, I often have conversations with patients trying to make thoughtful decisions about long-term therapies. Good medical decision-making requires looking at both sides of the equation — not just the potential side effects, but the risks of leaving the underlying condition untreated.

April 24, 2024 Read more →

In the Media

The Men's Health Conversation Most Men Never Have
YouTube · Video

The Men's Health Conversation Most Men Never Have

Watch on YouTube →
Testosterone and Men's Health: Dispelling the Myths
YouTube · Talk

Testosterone and Men's Health: Dispelling the Myths

Watch on YouTube →
The Future of Medicine Podcast with Dr. Steven Winiarski
YouTube · Podcast

The Future of Medicine Podcast with Dr. Steven Winiarski

Watch on YouTube →
Mastering Longevity – The Role of Lipid Management in Healthy Aging
YouTube · Podcast

Mastering Longevity – The Role of Lipid Management in Healthy Aging

Watch on YouTube →

Press inquiries: admin@cholesteroldoctors.com

Podcasts

Conversations on lipidology, longevity, and metabolic health — available on Spotify.

Get new writing by email

Occasional notes on lipids and metabolic health. Goes straight to Dr. Winiarski — no list broker, no third party.

Common questions

You work with me directly — not a rotating pool of providers. Board certified in Clinical Lipidology and Obesity Medicine, 25+ years in complex lipid and metabolic disease. You're paying for a specialist who knows your case, not a template.
No. The FDA has flagged compounded GLP-1s for ingredient purity, dosing accuracy, and lack of oversight, and they aren't FDA-approved. I prescribe only FDA-approved brand and generic medications through licensed pharmacies.
Not for membership — this is direct-pay, which is what buys the longer visits. Labs and imaging are billed to your insurance. I provide itemized receipts for HSA/FSA reimbursement.
Yes. I'm licensed in all 50 states and Washington, DC, so wherever you are in the US, you can be seen.
Yes — cancel anytime, no notice period and no cancellation fee. Membership is month-to-month unless you chose annual billing.
Cholesterol Doctors is aimed at providing expert treatment from a board-certified lipidologist to everyone in the US. Telemedicine has been proven to increase access to those who wouldn't get evaluated otherwise. The experience is superior to the traditional approach — no travel, no parking, no waiting room, longer visits.
Yes — it's one of the most common reasons patients come here. Your ApoB target doesn't change because you can't take a statin. Ezetimibe, bempedoic acid, and the PCSK9 inhibitors (Repatha, Leqvio, and oral Lipfendra) give us several routes to the same target. I'm equally glad to treat patients who simply prefer to avoid statins.
Good news, but not a discharge. Calcium scans detect calcified plaque only — soft, often more unstable plaque is invisible to them. They also look at the coronaries alone, while plaque forms in the carotid, aortic, iliofemoral, peripheral, and cerebral beds too. If your ApoB or Lp(a) is high, risk is still accumulating whatever the score says.
Yes. FH affects about 1 in 200 people and most don't know they have it. Because it causes high LDL and ApoB from birth rather than midlife, untreated FH drives cardiovascular events decades early — and it responds well to treatment once identified, usually with combination therapy. I also arrange cascade screening for first-degree relatives, since each has roughly a 50% chance of carrying it. Adults only; I'll help you find pediatric care for a child.
Yes — enlicitide (Lipfendra), FDA-approved July 2026, the first oral PCSK9 inhibitor. It joins the injectables: Repatha every 2–4 weeks and Leqvio twice a year. Which one depends on how far you are from target, what you've tried, and your coverage.
Whichever you prefer. Prescriptions go electronically to any licensed retail or mail-order pharmacy — no exclusive arrangement.

Ask a question

Goes straight to Dr. Winiarski. Usually answered the same day.

Email
admin@cholesteroldoctors.com
Membership
View membership plans →
Follow
Twitter / X LinkedIn

Start with the number that matters.

ApoB-guided cholesterol care from a board-certified lipidologist. $199/month, cancel anytime, licensed in all 50 states and DC.

Start care — $199/mo